Skip to content

Implantable Cardioverter-Defibrillator Use in the VA System

Implantable Cardioverter-Defibrillator (ICD) Utilization in a Potentially Eligible VA Population

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01217827
Enrollment
89
Registered
2010-10-08
Start date
2010-04-30
Completion date
2013-12-31
Last updated
2021-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathies

Brief summary

Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon prior research, a major barrier to low utilization is low referral of potential candidates by healthcare providers. In this study, via brief clinical reminder placed in the electronic medical record, we ask healthcare providers who have not referred potential candidates for defibrillator the reasons for this decision and provide them with the tools for referral if appropriate.

Interventions

Sponsors

Medtronic
CollaboratorINDUSTRY
VA Palo Alto Health Care System
CollaboratorFED
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Meeting published criteria for receipt of an implantable cardioverter defibrillator

Exclusion criteria

provider is not affiliated with the VA health care system

Design outcomes

Primary

MeasureTime frameDescription
Referral for Implantable Cardioverter Defibrillator6 monthsReferral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.

Countries

United States

Participant flow

Participants by arm

ArmCount
Clinical Reminder
Reminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient. Clinical Reminder
46
Control
This group does not receive an intervention.
43
Total89

Baseline characteristics

CharacteristicClinical ReminderControlTotal
Age, Continuous66 years
STANDARD_DEVIATION 8
64 years
STANDARD_DEVIATION 8
65 years
STANDARD_DEVIATION 8
Region of Enrollment
United States
46 participants43 participants89 participants
Sex: Female, Male
Female
3 Participants0 Participants3 Participants
Sex: Female, Male
Male
43 Participants43 Participants86 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 460 / 43
serious
Total, serious adverse events
1 / 464 / 43

Outcome results

Primary

Referral for Implantable Cardioverter Defibrillator

Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.

Time frame: 6 months

ArmMeasureValue (NUMBER)
Clinical ReminderReferral for Implantable Cardioverter Defibrillator11 participants
ControlReferral for Implantable Cardioverter Defibrillator1 participants

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026